FibroScan: Precision Risk Assessment for Fatty Liver and Liver Cirrhosis

HomeEducationHealth InformationFibroScan: Precision Risk Assessment for Fatty Liver and Liver Cirrhosis

FibroScan: Precision Risk Assessment for Fatty Liver and Liver Cirrhosis

2026-09-21 Gastroenterology and HepatologyHepatobiliary and Pancreatic Surgery Dr. SHARR Wei William Fatty Liver Disease and Cirrhosis


Among common chronic health risks in urban lifestyles, the threats of "fatty liver" and "liver fibrosis" should not be underestimated. Because the liver lacks pain nerves, early-stage lesions usually present no obvious symptoms. Without regular health checks, many patients often discover the issue unexpectedly only after it has progressed to mid-to-late stage liver cirrhosis.

To provide a fast, accurate, and comfortable examination experience, Chiron HBP Centre has introduced FibroScan (Liver Stiffness Measurement) technology.

Click to watch the FibroScan demonstration process and analyze key health indicators behind the report!

What is FibroScan?

FibroScan is a non-invasive, painless ultrasound procedure for the liver. It effectively measures liver stiffness (LSM) and controlled attenuation parameter (CAP) for fatty liver levels, enabling doctors and patients to fully understand the extent of liver damage.

Four Key Advantages of the FibroScan Examination Process:

  • Painless and Non-invasive: The patient lies flat on the bed with their right hand placed behind their head. Healthcare staff place a specialized probe on the skin between the ribs. The procedure only generates mild vibrations and is completely painless.
  • Fast and Time-saving: The entire scanning procedure takes only 5 to 10 minutes.
  • Instant Report: The examination report and data analysis can be obtained immediately after completion.
  • Accurate Grading: Clearly distinguishes between normal, mild, moderate, and severe levels of fatty liver and fibrosis.

Health Warning Signs Behind the Data

On the report, normal liver stiffness (LSM) values range between 2.3 kPa and 5.9 kPa, while the Controlled Attenuation Parameter (CAP) for fatty liver uses 248 dB/m as a reference threshold. However, when both sets of data are abnormally elevated, what kind of inflammation and fibrosis pressure is the liver undergoing? What clinical methods are available to reverse fatty liver in a timely manner?

Our professional team debunks diet and exercise myths regarding "reversing fatty liver": Click here
Learn more about fatty liver and liver cirrhosis in detail: Click here